-The Telegraph Centre’s vaccine policy advisers earlier this week approved release of intranasal vaccine into the private market New Delhi: Indian vaccine maker Bharat Biotech announced on Tuesday that its intranasal Covid-19 vaccine, approved by the Centre as a booster dose, would be available at private hospitals for Rs 800 plus additional taxes and service charges per dose. People 18 years or older who have taken two doses of Covaxin, Covishield or any...
More »SEARCH RESULT
Total Matching Records found : 5
As Covid Numbers Rise, Delhi Government Announces Free Booster Doses -Anindita Sanyal
-NDTV.com Delhi logged 965 fresh Covid cases over a 24-hour period on Thursday -- a positivity rate of 4.71 per cent -- while one person died due to the infection, according to data from the health department. New Delhi: The precautionary vaccine dose for Covid will be available free for the 18-59 age group in all hospitals run by the Delhi government. The Arvind Kejriwal government's order -- expected for a while...
More »Everyone Will Get Omicron, Boosters Won't Stop It: Top Medical Expert -Akhil Kumar
-NDTV.com "A majority of us will not know we have been infected, probably more than 80% will not even know when we have it," said Dr. Jaiprakash Muliyil. New Delhi: The Omicron variant of Covid-19 is "almost unstoppable" and everyone will eventually be infected with it, a top government expert told NDTV. Booster vaccine doses won't stop the rapid spread of the virus, he added. ''It makes no difference. The infection will...
More »Is India actually free of polio? -Vidya Krishnan
-The Hindu Why New Delhi must not bask in the WHO’s polio-free certification and, instead, have an ambitious plan to eradicate polio-like flaccid paralysis. On November 30, the day India introduced an Injectable Polio Vaccine (IPV) in its routine immunisation programme, stating that it “will be an important step in the Polio Endgame Strategy”, a case of Vaccine Derived Polio Virus (VDPV) was reported from New Delhi. This was the second such...
More »Meningitis: Indian vaccine will protect infants also -R Prasad
-The Hindu The vaccine, which is heat stable, is a great Indian success story A meningitis A vaccine (MenAfriVac) manufactured by Serum Institute of India, Pune was approved by WHO a few days ago for use in infants in sub-Saharan African populations. The vaccine will be introduced as part of the routine immunisation programme. "In the four years since its introduction in Africa, MenAfriVac has had an immediate and dramatic impact in breaking...
More »
